Methods for generating barcoded combinatorial libraries

US10287575B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10287575-B2
Application numberUS-201815948798-A
CountryUS
Kind codeB2
Filing dateApr 9, 2018
Priority dateJun 24, 2016
Publication dateMay 14, 2019
Grant dateMay 14, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided herein are methods and composition for trackable genetic variant libraries. Further provided herein are methods and compositions for recursive engineering. Further provided herein are methods and compositions for multiplex engineering. Further provided herein are methods and compositions for enriching for editing and trackable engineered sequences and cells using nucleic acid-guided nucleases.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of genome engineering, the method comprising: contacting a population of cells with a polynucleotide, such that at least one cell uptakes a first single molecule polynucleotide comprising a first editing cassette and a first recorder cassette, wherein: a), 1) the first editing cassette comprises: i) a modified first target nucleic acid sequence targeting a first target nucleic acid; ii) a first protospacer adjacent motif (PAM) mutation; iii) a first guide nucleic acid sequence targeting the first target nucleic acid and compatible with the nucleic acid-guided nuclease; and 2) the first recorder cassette comprises: i) a first barcode for tracking and identifying the modified first target nucleic acid sequence; and ii) a second guide nucleic acid sequence targeting the second target nucleic acid and compatible with the nucleic acid-guided nuclease; b) allowing the first guide nucleic acid sequence, the second guide nucleic acid sequence, and the nucleic acid-guided nuclease to create a genome edit within the first target nucleic acid and the second target nucleic acid; c) contacting said at least one cell with at least one additional single molecule polynucleotide comprising a second editing cassette and a second recorder cassette, wherein 3) the second editing cassette comprises: i) a modified third target nucleic acid sequence targeting a third target nucleic acid: ii) a second protospacer adjacent motif (PAM) mutation; and iii) a third guide nucleic acid sequence targeting the third target nucleic acid, and 4) the second recorder cassette comprises: i) a second barcode for tracking and identifying the modified third target nucleic acid sequence; and ii) a fourth guide nucleic acid sequence targeting a fourth target nucleic acid, wherein the fourth guide nucleic acid sequence is designed to incorporate the second barcode proximal to the first barcode forming a barcode array; and d) allowing the third guide nucleic acid sequence, the fourth guide nucleic acid sequence, and the nucleic acid-guided nuclease to create a genome edit within the third target nucleic acid and the fourth target nucleic acid, wherein the modified first target nucleic acid sequence is different to the modified third nucleic acid sequence, and wherein the second barcode is inserted adjacent to the first barcode, thereby forming a barcode array. 2. The method of claim 1 , further comprising e) sequencing the barcodes in a single reaction, thereby identifying the modified first and third target nucleic acids that were inserted within the first target nucleic acid in a) and c). 3. The method of claim 1 , wherein the first PAM mutation is not recognized by the nucleic acid-guided nuclease. 4. The method of claim 1 , wherein the second recorder cassette further comprises a second PAM mutation that is not recognized by the nucleic acid-guided nuclease. 5. The method of claim 1 , wherein the second recorder cassette targets a unique landing site. 6. The method of claim 1 , wherein the second target nucleic acid comprises a unique landing site. 7. The method of claim 1 , wherein the nucleic acid-guided nuclease comprises amino acid sequence SEQ ID NO: 7. 8. The method of claim 1 , wherein the nucleic acid-guided nuclease comprises amino acid sequence SEQ ID NO: 2. 9. A method of selectable recursive genetic engineering comprising a) contacting cells comprising a nucleic acid-guided nuclease with a polynucleotide comprising a recorder cassette, said recorder cassette comprising i) a nucleic acid sequence that recombines into a unique landing site, wherein the nucleic acid sequence comprises a barcode, wherein said barcode is a heterologous sequence engineered into said cells during a first round of said selectable recursive genetic engineering; and ii) a guide RNA compatible with the nucleic acid-guided nuclease that targets the unique landing site; and b) allowing the nucleic acid-guided nuclease to edit the unique landing site, thereby incorporating the barcode into the unique landing site; wherein the nucleic acid-guided nuclease comprises amino acid sequence SEQ ID NO: 2 or SEQ ID NO: 7, and repeating a) and b) during a second round of said selectable recursive genetic engineering. 10. The method of claim 9 , wherein the nucleic acid sequence further comprises a regulatory sequence that turns transcription of a screenable or selectable marker on or off. 11. The method of claim 9 , wherein the nucleic acid sequence further comprises a PAM mutation that is not compatible with the nucleic acid-guided nuclease. 12. The method of claim 9 , wherein the nucleic acid sequence further comprises a second unique landing site. 13. The method of claim 9 , wherein the polynucleotide further comprises an editing cassette comprising a) a modified first target nucleic acid sequence; b) a first protospacer adjacent motif (PAM) mutation; and c) a first guide nucleic acid sequence targeting the first target nucleic acid, wherein the modified first target nucleic acid can be tracked and identified by the barcode. 14. The method of claim 13 , wherein the modified first target nucleic acid sequence comprises at least one inserted, deleted, or substituted nucleotide. 15. The method of claim 13 , wherein the modified target nucleic acid sequence is within a coding region of the first target nucleic acid. 16. The method of claim 13 , wherein the modified target nucleic acid sequence is within a non-coding region of the first target nucleic acid.

Assignees

Inventors

Classifications

  • involving clustered regularly interspaced short palindromic repeats [CRISPR] · CPC title

  • Screening libraries by altering the phenotype or phenotypic trait of the host (reporter assays C12N15/1086) · CPC title

  • C12N15/102Primary

    Mutagenizing nucleic acids · CPC title

  • DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology, C07H21/00); {Non-coding nucleic acids having a biological activity} · CPC title

  • Preparation or screening of tagged libraries, e.g. tagged microorganisms by STM-mutagenesis, tagged polynucleotides, gene tags · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10287575B2 cover?
Provided herein are methods and composition for trackable genetic variant libraries. Further provided herein are methods and compositions for recursive engineering. Further provided herein are methods and compositions for multiplex engineering. Further provided herein are methods and compositions for enriching for editing and trackable engineered sequences and cells using nucleic acid-guided nu…
Who is the assignee on this patent?
Univ Colorado Regents, Inscripta Inc
What technology area does this patent fall under?
Primary CPC classification C12N15/102. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue May 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).